[a] The following abbreviations are used in this column: OEP =
dianion of octaethylporphyrin, bipy = 2,2′-bipyridine, phen =
1,10-phenanthroline, terpy = 2,2′:6′2′′-terpyridine, DBC =
dibenzo-18-crown-6, THF = tetrahydrofuran, TPP =
tetraphenylporphyrinate, LN4 =
N-[(1-H-imidazol-4-yl)methylene]-N′-(1-pyridin-2-yl-ethylidene)-2,2-dimethyl-propane-1,3-diamin,
TPpivP = ′′pivalamide-picket-fence′′ porphyrin, cyclam =
1,4,8,11-tetraazacyclotetradecane,
C22H34N4O5
= tetra-anion of
1,4,8,11-tetraaza-13,13-diethyl-2,2,5,5,7,7,10,10-octamethyl-3,6,9,12,14-pentaoxocyclote-tradecane,
C33H37N4 = dianion of
3,10,13,20-tetraethyl-4,9,14,19-tetramethylpentacyclo-tetracosa-2,4,6,8(23),9,12,14,16,18(21),19-decaene].
[b] Crystal structure contains µ-oxo-bis(trichloroferrate(III))
counteranion. [c] Crystal structure for (2,6-dichloro)OPh ligand.
[d] Crystal structure from ferric analogue. [e] Crystal
structure from ferrous analogue. [f] Crystal structure with azide
ligand.
|
[a] The following abbreviations are used in this column: OEP =
dianion of octaethylporphyrin, bipy = 2,2′-bipyridine, phen =
1,10-phenanthroline, terpy = 2,2′:6′2′′-terpyridine, DBC =
dibenzo-18-crown-6, THF = tetrahydrofuran, TPP =
tetraphenylporphyrinate, LN4 =
N-[(1-H-imidazol-4-yl)methylene]-N′-(1-pyridin-2-yl-ethylidene)-2,2-dimethyl-propane-1,3-diamin,
TPpivP = ′′pivalamide-picket-fence′′ porphyrin, cyclam =
1,4,8,11-tetraazacyclotetradecane,
C22H34N4O5
= tetra-anion of
1,4,8,11-tetraaza-13,13-diethyl-2,2,5,5,7,7,10,10-octamethyl-3,6,9,12,14-pentaoxocyclote-tradecane,
C33H37N4 = dianion of
3,10,13,20-tetraethyl-4,9,14,19-tetramethylpentacyclo-tetracosa-2,4,6,8(23),9,12,14,16,18(21),19-decaene].
[b] Crystal structure contains µ-oxo-bis(trichloroferrate(III))
counteranion. [c] Crystal structure for (2,6-dichloro)OPh ligand.
[d] Crystal structure from ferric analogue. [e] Crystal
structure from ferrous analogue. [f] Crystal structure with azide
ligand.
|
[a] The following abbreviations are used in this column: OEP =
dianion of octaethylporphyrin, bipy = 2,2′-bipyridine, phen =
1,10-phenanthroline, terpy = 2,2′:6′2′′-terpyridine, DBC =
dibenzo-18-crown-6, THF = tetrahydrofuran, TPP =
tetraphenylporphyrinate, LN4 =
N-[(1-H-imidazol-4-yl)methylene]-N′-(1-pyridin-2-yl-ethylidene)-2,2-dimethyl-propane-1,3-diamin,
TPpivP = ′′pivalamide-picket-fence′′ porphyrin, cyclam =
1,4,8,11-tetraazacyclotetradecane,
C22H34N4O5
= tetra-anion of
1,4,8,11-tetraaza-13,13-diethyl-2,2,5,5,7,7,10,10-octamethyl-3,6,9,12,14-pentaoxocyclote-tradecane,
C33H37N4 = dianion of
3,10,13,20-tetraethyl-4,9,14,19-tetramethylpentacyclo-tetracosa-2,4,6,8(23),9,12,14,16,18(21),19-decaene].
[b] Crystal structure contains µ-oxo-bis(trichloroferrate(III))
counteranion. [c] Crystal structure for (2,6-dichloro)OPh ligand.
[d] Crystal structure from ferric analogue. [e] Crystal
structure from ferrous analogue. [f] Crystal structure with azide
ligand.
|
[a] The following abbreviations are used in this column: OEP =
dianion of octaethylporphyrin, bipy = 2,2′-bipyridine, phen =
1,10-phenanthroline, terpy = 2,2′:6′2′′-terpyridine, DBC =
dibenzo-18-crown-6, THF = tetrahydrofuran, TPP =
tetraphenylporphyrinate, LN4 =
N-[(1-H-imidazol-4-yl)methylene]-N′-(1-pyridin-2-yl-ethylidene)-2,2-dimethyl-propane-1,3-diamin,
TPpivP = ′′pivalamide-picket-fence′′ porphyrin, cyclam =
1,4,8,11-tetraazacyclotetradecane,
C22H34N4O5
= tetra-anion of
1,4,8,11-tetraaza-13,13-diethyl-2,2,5,5,7,7,10,10-octamethyl-3,6,9,12,14-pentaoxocyclote-tradecane,
C33H37N4 = dianion of
3,10,13,20-tetraethyl-4,9,14,19-tetramethylpentacyclo-tetracosa-2,4,6,8(23),9,12,14,16,18(21),19-decaene].
[b] Crystal structure contains µ-oxo-bis(trichloroferrate(III))
counteranion. [c] Crystal structure for (2,6-dichloro)OPh ligand.
[d] Crystal structure from ferric analogue. [e] Crystal
structure from ferrous analogue. [f] Crystal structure with azide
ligand.
|
[a] The following abbreviations are used in this column: OEP =
dianion of octaethylporphyrin, bipy = 2,2′-bipyridine, phen =
1,10-phenanthroline, terpy = 2,2′:6′2′′-terpyridine, DBC =
dibenzo-18-crown-6, THF = tetrahydrofuran, TPP =
tetraphenylporphyrinate, LN4 =
N-[(1-H-imidazol-4-yl)methylene]-N′-(1-pyridin-2-yl-ethylidene)-2,2-dimethyl-propane-1,3-diamin,
TPpivP = ′′pivalamide-picket-fence′′ porphyrin, cyclam =
1,4,8,11-tetraazacyclotetradecane,
C22H34N4O5
= tetra-anion of
1,4,8,11-tetraaza-13,13-diethyl-2,2,5,5,7,7,10,10-octamethyl-3,6,9,12,14-pentaoxocyclote-tradecane,
C33H37N4 = dianion of
3,10,13,20-tetraethyl-4,9,14,19-tetramethylpentacyclo-tetracosa-2,4,6,8(23),9,12,14,16,18(21),19-decaene].
[b] Crystal structure contains µ-oxo-bis(trichloroferrate(III))
counteranion. [c] Crystal structure for (2,6-dichloro)OPh ligand.
[d] Crystal structure from ferric analogue. [e] Crystal
structure from ferrous analogue. [f] Crystal structure with azide
ligand.
|
[a] The following abbreviations are used in this column: OEP =
dianion of octaethylporphyrin, bipy = 2,2′-bipyridine, phen =
1,10-phenanthroline, terpy = 2,2′:6′2′′-terpyridine, DBC =
dibenzo-18-crown-6, THF = tetrahydrofuran, TPP =
tetraphenylporphyrinate, LN4 =
N-[(1-H-imidazol-4-yl)methylene]-N′-(1-pyridin-2-yl-ethylidene)-2,2-dimethyl-propane-1,3-diamin,
TPpivP = ′′pivalamide-picket-fence′′ porphyrin, cyclam =
1,4,8,11-tetraazacyclotetradecane,
C22H34N4O5
= tetra-anion of
1,4,8,11-tetraaza-13,13-diethyl-2,2,5,5,7,7,10,10-octamethyl-3,6,9,12,14-pentaoxocyclote-tradecane,
C33H37N4 = dianion of
3,10,13,20-tetraethyl-4,9,14,19-tetramethylpentacyclo-tetracosa-2,4,6,8(23),9,12,14,16,18(21),19-decaene].
[b] Crystal structure contains µ-oxo-bis(trichloroferrate(III))
counteranion. [c] Crystal structure for (2,6-dichloro)OPh ligand.
[d] Crystal structure from ferric analogue. [e] Crystal
structure from ferrous analogue. [f] Crystal structure with azide
ligand.
|
[a] The following abbreviations are used in this column: OEP =
dianion of octaethylporphyrin, bipy = 2,2′-bipyridine, phen =
1,10-phenanthroline, terpy = 2,2′:6′2′′-terpyridine, DBC =
dibenzo-18-crown-6, THF = tetrahydrofuran, TPP =
tetraphenylporphyrinate, LN4 =
N-[(1-H-imidazol-4-yl)methylene]-N′-(1-pyridin-2-yl-ethylidene)-2,2-dimethyl-propane-1,3-diamin,
TPpivP = ′′pivalamide-picket-fence′′ porphyrin, cyclam =
1,4,8,11-tetraazacyclotetradecane,
C22H34N4O5
= tetra-anion of
1,4,8,11-tetraaza-13,13-diethyl-2,2,5,5,7,7,10,10-octamethyl-3,6,9,12,14-pentaoxocyclote-tradecane,
C33H37N4 = dianion of
3,10,13,20-tetraethyl-4,9,14,19-tetramethylpentacyclo-tetracosa-2,4,6,8(23),9,12,14,16,18(21),19-decaene].
[b] Crystal structure contains µ-oxo-bis(trichloroferrate(III))
counteranion. [c] Crystal structure for (2,6-dichloro)OPh ligand.
[d] Crystal structure from ferric analogue. [e] Crystal
structure from ferrous analogue. [f] Crystal structure with azide
ligand.
|
[a] The following abbreviations are used in this column: OEP =
dianion of octaethylporphyrin, bipy = 2,2′-bipyridine, phen =
1,10-phenanthroline, terpy = 2,2′:6′2′′-terpyridine, DBC =
dibenzo-18-crown-6, THF = tetrahydrofuran, TPP =
tetraphenylporphyrinate, LN4 =
N-[(1-H-imidazol-4-yl)methylene]-N′-(1-pyridin-2-yl-ethylidene)-2,2-dimethyl-propane-1,3-diamin,
TPpivP = ′′pivalamide-picket-fence′′ porphyrin, cyclam =
1,4,8,11-tetraazacyclotetradecane,
C22H34N4O5
= tetra-anion of
1,4,8,11-tetraaza-13,13-diethyl-2,2,5,5,7,7,10,10-octamethyl-3,6,9,12,14-pentaoxocyclote-tradecane,
C33H37N4 = dianion of
3,10,13,20-tetraethyl-4,9,14,19-tetramethylpentacyclo-tetracosa-2,4,6,8(23),9,12,14,16,18(21),19-decaene].
[b] Crystal structure contains µ-oxo-bis(trichloroferrate(III))
counteranion. [c] Crystal structure for (2,6-dichloro)OPh ligand.
[d] Crystal structure from ferric analogue. [e] Crystal
structure from ferrous analogue. [f] Crystal structure with azide
ligand.
|